• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单功能化糖基化铂(IV)配合物具有pH和氧化还原双重响应特性:在体外和体内均表现出更高的安全性并优先在癌细胞中积累。

Mono-functionalized glycosylated platinum(IV) complexes possessed both pH and redox dual-responsive properties: Exhibited enhanced safety and preferentially accumulated in cancer cells in vitro and in vivo.

作者信息

Ma Jing, Yang Xiande, Hao Wenpei, Huang Zhonglv, Wang Xin, Wang Peng George

机构信息

College of Pharmacy, State Key Laboratory of Elemento-organic Chemistry, Nankai University, Tianjin 300071, PR China.

College of Pharmacy, State Key Laboratory of Elemento-organic Chemistry, Nankai University, Tianjin 300071, PR China; Tianjin Key Laboratory of Molecular Drug Research, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University, Tianjin 300071, PR China.

出版信息

Eur J Med Chem. 2017 Mar 10;128:45-55. doi: 10.1016/j.ejmech.2017.01.032. Epub 2017 Jan 23.

DOI:10.1016/j.ejmech.2017.01.032
PMID:28147308
Abstract

A serious of carbohydrate-conjugated platinum(IV) complexes in the form Pt(L2)(A2)(OH)R based on the clinical drug cisplatin and oxaliplatin were designed, synthesized and evaluated as antitumor agents in vitro and in vivo. The conjugates possessing both pH and redox dual-responsive properties exhibited more potent cytotoxicity in seven different human cancer cell lines and lower toxicity to the normal 3T3 cells than cisplatin, oxaliplatin and even the reported bis-functionalized glycosylated platinum(IV) complexes indicating the enhanced safety of the sugar conjugates. Cellular drug uptake and DNA platination were also superior to cisplatin, oxaliplatin and the reported bis-functionalized ones. Peak current of B7 and B8 with the scan rate of 200mv/s at the concentration of 0.08 mM was 5-fold higher at pH 6.4 than the pH 7.4, indicating that carbohydrate-conjugated mono-functionalized platinum(IV) complexes possessed both pH and redox dual-responsive properties in the cancer cells. The in vivo assays demonstrated that the Pt(IV) compounds could inhibit the growth of MCF-7 tumour and exert more safety than oxaliplatin.

摘要

基于临床药物顺铂和奥沙利铂,设计、合成了一系列Pt(L2)(A2)(OH)R形式的碳水化合物共轭铂(IV)配合物,并在体外和体内作为抗肿瘤剂进行了评估。具有pH和氧化还原双重响应特性的共轭物在七种不同的人类癌细胞系中表现出更强的细胞毒性,对正常3T3细胞的毒性低于顺铂、奥沙利铂,甚至低于已报道的双功能糖基化铂(IV)配合物,表明糖共轭物的安全性有所提高。细胞药物摄取和DNA铂化也优于顺铂、奥沙利铂和已报道的双功能化化合物。在0.08 mM浓度下,扫描速率为200mv/s时,B7和B8在pH 6.4时的峰值电流比pH 7.4时高5倍,表明碳水化合物共轭单功能铂(IV)配合物在癌细胞中具有pH和氧化还原双重响应特性。体内试验表明,Pt(IV)化合物可以抑制MCF-7肿瘤的生长,并且比奥沙利铂更安全。

相似文献

1
Mono-functionalized glycosylated platinum(IV) complexes possessed both pH and redox dual-responsive properties: Exhibited enhanced safety and preferentially accumulated in cancer cells in vitro and in vivo.单功能化糖基化铂(IV)配合物具有pH和氧化还原双重响应特性:在体外和体内均表现出更高的安全性并优先在癌细胞中积累。
Eur J Med Chem. 2017 Mar 10;128:45-55. doi: 10.1016/j.ejmech.2017.01.032. Epub 2017 Jan 23.
2
Design, synthesis and biological evaluation of a novel series of glycosylated platinum(iv) complexes as antitumor agents.新型糖基化铂(IV)配合物作为抗肿瘤药物的设计、合成及生物学评价
Dalton Trans. 2016 Jun 21;45(25):10366-74. doi: 10.1039/c6dt01562j.
3
Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents.不同糖基共轭2-甲基丙二酸铂(II)配合物作为新型肿瘤靶向剂的作用机制和生物学特性
Eur J Med Chem. 2017 Jan 5;125:372-384. doi: 10.1016/j.ejmech.2016.09.047. Epub 2016 Sep 16.
4
Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery.糖基化铂(IV)配合物作为葡萄糖转运体(GLUTs)和有机阳离子转运体(OCTs)的底物,表现出癌症靶向和人血清白蛋白结合特性,可用于药物递送。
J Med Chem. 2017 Jul 13;60(13):5736-5748. doi: 10.1021/acs.jmedchem.7b00433. Epub 2017 Jun 27.
5
Glucose-conjugated platinum(IV) complexes as tumor-targeting agents: design, synthesis and biological evaluation.葡萄糖结合的铂(IV)配合物作为肿瘤靶向剂:设计、合成与生物评价。
Bioorg Med Chem. 2019 Apr 15;27(8):1639-1645. doi: 10.1016/j.bmc.2019.03.006. Epub 2019 Mar 2.
6
Glycosylated platinum(iv) prodrugs demonstrated significant therapeutic efficacy in cancer cells and minimized side-effects.糖基化铂(IV)前药在癌细胞中显示出显著的治疗效果,并将副作用降至最低。
Dalton Trans. 2016 Jul 19;45(29):11830-8. doi: 10.1039/c6dt02207c.
7
Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.用于顺铂前药的pH和氧化还原响应递送的人血清白蛋白缀合纳米颗粒
Chemistry. 2015 Nov 9;21(46):16547-54. doi: 10.1002/chem.201502756. Epub 2015 Sep 25.
8
Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.轴向和赤道配体对反式-1R,2R-二氨基环己烷铂(IV)配合物抗肿瘤活性的调节作用。
Anticancer Drug Des. 1994 Apr;9(2):139-51.
9
Comparative studies of oxaliplatin-based platinum(iv) complexes in different in vitro and in vivo tumor models.基于奥沙利铂的铂(IV)配合物在不同体外和体内肿瘤模型中的比较研究。
Metallomics. 2017 Mar 22;9(3):309-322. doi: 10.1039/c6mt00226a.
10
Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.双乙酸根-氨-二氯-环己胺铂(IV)的临床前抗肿瘤评估:一种口服活性铂类药物
Cancer Res. 1993 Jun 1;53(11):2581-6.

引用本文的文献

1
2D and 3D anticancer properties of C2-functionalised glucosamine-Pt (IV) prodrugs based on cisplatin scaffold.基于顺铂支架的C2-官能化葡糖胺-Pt(IV)前药的二维和三维抗癌特性
Front Chem. 2024 May 6;12:1388332. doi: 10.3389/fchem.2024.1388332. eCollection 2024.
2
Suppression of lysosome metabolism-meditated GARP/TGF-β1 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis.抑制溶酶体代谢介导的 GARP/TGF-β1 复合物可特异性耗竭调节性 T 细胞,从而抑制乳腺癌转移。
Oncogene. 2024 Jun;43(25):1930-1940. doi: 10.1038/s41388-024-03043-y. Epub 2024 May 2.
3
Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity.
Pt(IV) 配合物在新型铂前药探索中的应用:具有潜在活性的药物。
Top Curr Chem (Cham). 2024 Feb 24;382(1):6. doi: 10.1007/s41061-023-00448-3.
4
Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy.用于奥沙利铂癌症治疗的位点特异性递送的纳米结构:协同癌症治疗中的多功能纳米平台。
Transl Oncol. 2024 Jan;39:101838. doi: 10.1016/j.tranon.2023.101838. Epub 2023 Nov 27.
5
Lysosome blockade induces divergent metabolic programs in macrophages and tumours for cancer immunotherapy.溶酶体阻断在巨噬细胞和肿瘤中诱导不同的代谢程序,用于癌症免疫治疗。
J Exp Clin Cancer Res. 2023 Aug 4;42(1):192. doi: 10.1186/s13046-023-02768-0.
6
Stimuli-responsive nanocarrier delivery systems for Pt-based antitumor complexes: a review.基于铂的抗肿瘤复合物的刺激响应性纳米载体递送系统:综述
RSC Adv. 2023 Jun 1;13(24):16488-16511. doi: 10.1039/d3ra00866e. eCollection 2023 May 30.
7
Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma.新型 Pt(IV)-碳水化合物衍生物作为针对骨肉瘤的靶向抗癌药物的研发。
Int J Mol Sci. 2023 Mar 23;24(7):6028. doi: 10.3390/ijms24076028.
8
Synthesis and Antiparasitic Activity of New Trithiolato-Bridged Dinuclear Ruthenium(II)-arene-carbohydrate Conjugates.新型三硫代桥联双核钌(II)-芳基-碳水化合物轭合物的合成及抗寄生虫活性。
Molecules. 2023 Jan 16;28(2):902. doi: 10.3390/molecules28020902.
9
Potential Anticancer Activities and Catalytic Oxidation Efficiency of Platinum(IV) Complex.铂(IV)配合物的潜在抗癌活性和催化氧化效率。
Molecules. 2022 Jul 9;27(14):4406. doi: 10.3390/molecules27144406.
10
Synthesis and Preliminary Evaluation of the Cytotoxicity of Potential Metabolites of Quinoline Glycoconjugates.喹啉糖缀合物潜在代谢物的合成及细胞毒性的初步评价。
Molecules. 2022 Feb 3;27(3):1040. doi: 10.3390/molecules27031040.